美国上市药品(最近批准)
按批准日期最近更新
| 药品名称 | 商品名 | 申请号 | 产品编号 | 剂型 | 规格 | 企业 | 市场状态 | 批准日期 | 上市日期 |
|---|---|---|---|---|---|---|---|---|---|
| VILOXAZINE HYDROCHLORIDE | VILOXAZINE HYDROCHLORIDE | ANDA220376 | 003 | CAPSULE, EXTENDED RELEASE | 150MG | ZENARA PHARMA PRIVATE LTD | None (Tentative Approval) | 2026-10-08 | 2026-10-08 |
| MIRABEGRON | MIRABEGRON | ANDA219599 | 001 | TABLET, EXTENDED RELEASE;ORAL | 25MG | CREEKWOOD PHARMS | Prescription | 2026-10-07 | 2026-10-07 |
| MIRABEGRON | MIRABEGRON | ANDA219599 | 002 | TABLET, EXTENDED RELEASE;ORAL | 50MG | CREEKWOOD PHARMS | Prescription | 2026-10-07 | 2026-10-07 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | ANDA218248 | 001 | SOLUTION;ORAL | 50MG/5ML | RUBICON RESEARCH | Prescription | 2026-10-07 | 2026-10-07 |
| FIDAXOMICIN | FIDAXOMICIN | ANDA219737 | 001 | TABLET;ORAL | 200MG | HIKMA | Prescription | 2026-10-07 | 2026-10-07 |
| SOLRIAMFETOL HYDROCHLORIDE | SOLRIAMFETOL HYDROCHLORIDE | ANDA218725 | 001 | TABLET | 150MG | AUROBINDO PHARMA LTD | None (Tentative Approval) | 2026-10-06 | 2026-10-06 |
| SOLRIAMFETOL HYDROCHLORIDE | SOLRIAMFETOL HYDROCHLORIDE | ANDA218725 | 002 | TABLET;ORAL | EQ 75MG BASE | AUROBINDO PHARMA LTD | Prescription | 2026-10-06 | 2026-10-06 |
| SOLRIAMFETOL HYDROCHLORIDE | SOLRIAMFETOL HYDROCHLORIDE | ANDA218725 | 003 | TABLET;ORAL | EQ 150MG BASE | AUROBINDO PHARMA LTD | Prescription | 2026-10-06 | 2026-10-06 |
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | ANDA215701 | 001 | INJECTABLE;INJECTION | 200MG/2ML(100MG/ML) | SHANDONG | None (Tentative Approval) | 2026-10-06 | 2026-10-06 |
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | ANDA215701 | 002 | INJECTABLE;INJECTION | 500MG/5ML(100MG/ML) | SHANDONG | None (Tentative Approval) | 2026-10-06 | 2026-10-06 |
上一页 第 3 / 3 页 下一页